ABIVAX
Last · Paris€79.25+2.30 (+2.99%)close · yahoo · 19h ago
Vol 115.9K ≈ 9.19M
MA10MA20MA50
Market cap€6.9B87.3M sh
P/E · TTM-15.2fwd -27.3 · eps -5.21 · loss
Beta-0.23vs S&P 500
Div yield0.00%annual · TTM
52w range
€60.45€139.00
Volume115.9Ksession
Issuer
Legal nameABIVAX
HQEurope (EU)
ListingEU ABVX
ISINFR0012333284
SectorHealthcare
IndustryBiotechnology & Medical Research
CurrencyEUR
Entity registrylei:969500D8TMNB184OJU95
CIK0001956827
Websitewww.abivax.com
Employees80
AddressAbivax SA 7-11 Boulevard Haussmann 75009, Paris +33 1 53 83 09 63
Loading chart…
OpenFilings analyst
Our analyst
ANNUAL · 2025-04-15
From latest ANNUAL · 2025-04-15
- Operating Cf Burn
- Cash Runway Low
Red flags
- Operating Cf Burn — Negative operating cash flow
- Cash Runway Low — Cash runway ~0.9 years
Press & signals
- GlobeNewswire
Abivax Presents Business Updates and First Half 2026 Financial Results
- GlobeNewswire
Abivax Announces Closing of $920 Million Public Offering
- GlobeNewswire
Abivax Announces Full Exercise of Underwriters’ Option to Purchase Additional ADSs, Bringing Gross Proceeds of Offering to $920M (€807M)
The rest of this company's wire — with summaries and source links — is part of Pro.
See plansDocuments
FormReporting forFiledFlags
Showing 5 of 616 filings